Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles (2014 - 2017)
Amphastar Pharmaceuticals (AMPH) posted quarterly Amortizatization of Intangibles of $7000.0 for Q2 2017, down 61.11% year-over-year from $18000.0 in Q2 2016, and down 22.22% quarter-over-quarter from $9000.0 in Q1 2017.
Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles (2014 - 2017) Analysis & Trends
Amphastar Pharmaceuticals' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $7000.0 for Q2 2017.
- In Q2 2017, Amortizatization of Intangibles fell 61.11% year-over-year to $7000.0; the TTM figure through Jun 2017 stood at $52000.0 (down 42.22% YoY), while the FY2016 annual figure was $72000.0, down 34.55% from the prior year.
- Amortizatization of Intangibles for Q2 2017 stood at $7000.0, down from $9000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $97000.0 in Q4 2014, with the low at $7000.0 in Q2 2017.
- The 4-year median for Amortizatization of Intangibles is $19000.0 (2016), against an average of $26818.2.
- The sharpest annual moves came in 2015 and 2016: Amortizatization of Intangibles slumped 72.16% in 2015, then slipped 29.63% in 2016.
- Amphastar Pharmaceuticals' Amortizatization of Intangibles stood at $97000.0 in 2014, then plunged by 72.16% to $27000.0 in 2015, then slumped by 37.04% to $17000.0 in 2016, then tumbled by 58.82% to $7000.0 in 2017.
- Business Quant data shows AMPH's Amortizatization of Intangibles at $7000.0 in Q2 2017, $9000.0 in Q1 2017, and $17000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 938.78 Mn | 648.66 Mn | 93.47 Mn | 2.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 7,000.00 |
| Mar 31, 2017 | 9,000.00 |
| Mar 31, 2017 | 9,000.00 |
| Dec 31, 2016 | 17,000.00 |
| Dec 31, 2016 | 17,000.00 |
| Sep 30, 2016 | 19,000.00 |
| Sep 30, 2016 | 19,000.00 |
| Jun 30, 2016 | 18,000.00 |
| Jun 30, 2016 | 18,000.00 |
| Mar 31, 2016 | 18,000.00 |
| Mar 31, 2016 | 18,000.00 |
| Dec 31, 2015 | 27,000.00 |
| Dec 31, 2015 | 27,000.00 |
| Sep 30, 2015 | 27,000.00 |
| Sep 30, 2015 | 27,000.00 |
| Jun 30, 2015 | 28,000.00 |
| Jun 30, 2015 | 28,000.00 |
| Mar 31, 2015 | 28,000.00 |
| Mar 31, 2015 | 28,000.00 |